Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$25.60

0.65 (2.61%)

06:21
02/15/18
02/15
06:21
02/15/18
06:21

Acorda Therapeutics sees FY18 AMPYRA net revenue $330M-$350M

The company expects to maintain exclusivity of AMPYRA at least through July 30, 2018; this guidance is subject to change based on the appellate court's decision. R&D expenses for the full year 2018 are expected to be $100M-$110M and include manufacturing expenses associated with INBRIJA. This guidance is a non-GAAP projection that excludes share-based compensation. SG&A expenses for the full year 2018 are expected to be $170M-$180M. This guidance is a non-GAAP projection. Year-end cash balance for 2018 is projected to be over $300M.

  • 15

    Feb

  • 15

    Feb

ACOR Acorda Therapeutics
$25.60

0.65 (2.61%)

11/21/17
JANY
11/21/17
NO CHANGE
Target $17
JANY
Neutral
Acorda could be worth $17-$27 in takeover, says Janney Capital
After Acorda Therapeutics announced that it is discontinuing development of tozadenant, an investigational treatment for Parkinson's disease, Janney Capital analyst Ken Trbovich said he believes a sale process appears necessary to protect shareholders from downside that he sees if Acorda remains independent. While the stock may only be worth $10-$11 if Acorda stays independent, it could be worth $17-$27 in a takeout scenario, estimated Trbovich, who maintains a Neutral rating and $17 fair value estimate on Acorda shares.
11/28/17
PIPR
11/28/17
INITIATION
Target $22
PIPR
Neutral
Acorda Therapeutics assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Charles Duncan assumed coverage of Acorda Therapeutics with a Neutral rating and $22 price target. The analyst believes Inbrija could be a best-in-class acute treatment with $800M in peak U.S. sales. He's looking for clinical and regulatory progress "which re-establishes conviction in Acorda's execution."
01/31/18
JANY
01/31/18
NO CHANGE
JANY
Neutral
Competitor Phase 3 'takes some shine off' Acorda Therapeutics, says Janney Capital
Janney Capital analyst Ken Trbovich notes that Sunovion Pharmaceuticals, a wholly owned U.S.-based subsidiary of Sumitomo Dainippon Pharma, reported positive top-line results from its Phase 3 trial of APL-130277 for treating OFF-rescue in Parkinson's Disease patients. While the respective Phase 3 studies were not head-to-head, it would appear APL-130277 may be the more potent OFF rescue treatment, with the trade-off being higher rates unpleasant side effects such as nausea and dizziness, the analyst notes. Trbovich believes this could take some of the luster off perceived M&A value of Acorda Therapeutics, but it is unlikely to eliminate interest. He reiterates a Neutral rating on Acorda Therapeutics' shares.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $25
JEFF
Hold
Acorda remains takeover candidate after competitor data, says Jefferies
Jefferies analyst Michael Yee believes the positive Phase III topline results from Acorda Therapeutics (ACOR) competitor Sunovion for APL-130277 in Parkinson's patients came in as expected. While APL-130277 data compares favorably over Inbrija's 3.92 point difference at week 12, Yee cautions to compare directly head-to-head since patient baseline characteristics could be different. Acorda remains a "reasonably likely" acquisition candidate in 2018 given its $300M-$500M-plus Parkinson's asset Inbrija, Yee tells investors in a research note. The analyst does not think Biogen (BIIB) should buy the company, but sees other potential suitors in AbbVie (ABBV), Allergan (AGN), Mitsubishi, Roche (RHHBY) and Shire (SHPG). He believes a takeover price could be north of $2B. Yee keeps a Hold rating on Acorda with a $25 price target.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$314.93

0.3 (0.10%)

, ALKS

Alkermes

$33.30

0.52 (1.59%)

10:16
12/17/18
12/17
10:16
12/17/18
10:16
Recommendations
Biogen, Alkermes analyst commentary  »

Piper says Biogen's…

BIIB

Biogen

$314.93

0.3 (0.10%)

ALKS

Alkermes

$33.30

0.52 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/17/18
12/17
10:16
12/17/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/17/18
12/17
10:15
12/17/18
10:15
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

FII

Federated Investors

$24.92

0.27 (1.10%)

, TLC

Taiwan Liposome

$6.01

(0.00%)

10:13
12/17/18
12/17
10:13
12/17/18
10:13
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FII

Federated Investors

$24.92

0.27 (1.10%)

TLC

Taiwan Liposome

$6.01

(0.00%)

TRUE

TrueCar

$9.54

-0.26 (-2.65%)

SKX

Skechers

$22.84

-0.06 (-0.26%)

ZION

Zions Bancorp

$41.64

0.1 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$53.65

-1.72 (-3.11%)

, ITW

Illinois Tool Works

$128.94

-2.08 (-1.59%)

10:13
12/17/18
12/17
10:13
12/17/18
10:13
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

BBY

Best Buy

$53.65

-1.72 (-3.11%)

ITW

Illinois Tool Works

$128.94

-2.08 (-1.59%)

CPK

Chesapeake Utilities

$92.02

-0.98 (-1.05%)

MSEX

Middlesex Water

$57.23

-1.41 (-2.40%)

ELY

Callaway Golf

$15.85

-0.79 (-4.75%)

CNC

Centene

$118.64

-8.91 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

SWK

Stanley Black & Decker

$119.09

0.73 (0.62%)

, CLXT

Calyxt

$9.70

-0.18 (-1.82%)

10:13
12/17/18
12/17
10:13
12/17/18
10:13
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

SWK

Stanley Black & Decker

$119.09

0.73 (0.62%)

CLXT

Calyxt

$9.70

-0.18 (-1.82%)

SMG

Scotts Miracle-Gro

$64.23

0.73 (1.15%)

LULU

Lululemon

$118.08

-1.05 (-0.88%)

BKS

Barnes & Noble

$6.52

0.03 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Jan

VXX

iPath S&P 500 VIX Short-Term Futures

$41.29

0.76 (1.88%)

10:10
12/17/18
12/17
10:10
12/17/18
10:10
Options
Bearish spread opened in iPath S&P 500 VIX Short Term Futures ETN »

Bearish spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
12/17/18
12/17
10:10
12/17/18
10:10
General news
U.S. NAHB housing market index fell 4 points to 56 in December »

U.S. NAHB housing market…

CBPO

China Biologic

$71.38

-0.56 (-0.78%)

10:09
12/17/18
12/17
10:09
12/17/18
10:09
Hot Stocks
David Gao 'disappointed' over dismissal of lawsuit against China Biologic »

David Gao, a shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSG

Madison Square Garden

$261.94

0.48 (0.18%)

10:08
12/17/18
12/17
10:08
12/17/18
10:08
Periodicals
Dolan says would consider selling Knicks for 'bona fide' offer, ESPN reports »

James Dolan, the chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$11.35

-3.46 (-23.36%)

10:08
12/17/18
12/17
10:08
12/17/18
10:08
Hot Stocks
Breaking Hot Stocks news story on Dova Pharmaceuticals »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

CAR

Avis Budget

$24.75

-0.26 (-1.04%)

, IDSY

I.D. Systems

$5.29

(0.00%)

10:07
12/17/18
12/17
10:07
12/17/18
10:07
Hot Stocks
Avis Budget to connect additional 75,000 cars though I.D. Systems devices »

Avis Budget Group (CAR)…

CAR

Avis Budget

$24.75

-0.26 (-1.04%)

IDSY

I.D. Systems

$5.29

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

$52.68

-0.86 (-1.61%)

10:04
12/17/18
12/17
10:04
12/17/18
10:04
Hot Stocks
Lincoln Financial Group announces eMoney, Redtail integrations »

Lincoln Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$11.93

-2.88 (-19.45%)

10:03
12/17/18
12/17
10:03
12/17/18
10:03
Hot Stocks
Breaking Hot Stocks news story on Dova Pharmaceuticals »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

10:01
12/17/18
12/17
10:01
12/17/18
10:01
General news
Housing Market Index data reported »

December Housing Market…

UGAZ

VelocityShares 3x Long Natural Gas ETN

$84.44

-7.56 (-8.22%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -8.3% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$116.87

-10.68 (-8.37%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
Centene falls -8.4% »

Centene is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

MOH

Molina Healthcare

$111.84

-19.88 (-15.09%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
Molina Healthcare falls -14.7% »

Molina Healthcare is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBD

Banco Bradesco

$9.67

-0.08 (-0.82%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Options
Bearish option flow in Banco Bradesco »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$84.90

6.21 (7.89%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 8.1% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDE

Coeur Mining

$4.13

0.31 (8.12%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
Coeur Mining rises 8.7% »

Coeur Mining is up 8.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$3.24

0.275 (9.27%)

10:00
12/17/18
12/17
10:00
12/17/18
10:00
Hot Stocks
Alamos Gold rises 9.1% »

Alamos Gold is up 9.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFFN

Diffusion Pharmaceuticals

$2.89

0.02 (0.70%)

09:59
12/17/18
12/17
09:59
12/17/18
09:59
Hot Stocks
Diffusion Pharmaceuticals awarded patent for use of TSC in conjuction with tPA »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$42.41

-0.98 (-2.26%)

09:57
12/17/18
12/17
09:57
12/17/18
09:57
Options
International Paper put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$298.75

-1.66 (-0.55%)

, UNH

UnitedHealth

$258.80

-6.26 (-2.36%)

09:56
12/17/18
12/17
09:56
12/17/18
09:56
On The Fly
Healthcare, hospital stocks slide as judge rules ACA 'unconstitutional' »

Major healthcare and…

HUM

Humana

$298.75

-1.66 (-0.55%)

UNH

UnitedHealth

$258.80

-6.26 (-2.36%)

CNC

Centene

$115.98

-11.57 (-9.07%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$268.16

-7.43 (-2.70%)

CI

Cigna

$199.97

-5.37 (-2.62%)

HNT

Health Net

$0.00

(0.00%)

HCA

HCA Healthcare

$120.30

-6.36 (-5.02%)

THC

Tenet

$19.92

-1.32 (-6.21%)

CYH

Community Health

$3.61

-0.305 (-7.79%)

MOH

Molina Healthcare

$111.98

-19.74 (-14.99%)

WCG

WellCare

$224.83

-12.07 (-5.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.